北京市政府近日发布《北京市加快医药健康协同创新行动计划(2024-2026年)》，旨在推动本市医药健康产业的高速发展。根据计划，北京将力争在未来的三年内，将医药健康产业的总规模提升至1.25万亿元人民币，同时每年确保至少100亿元以上的固定资产投资。
这一目标不仅展示了北京市对于医药健康产业的重视，也预示着该产业在未来几年内将迎来快速发展的黄金期。计划中提到，将通过加强创新平台建设、优化产业结构、提升研发能力等多项措施，推动医药健康产业实现跨越式发展。
北京市作为中国首都，拥有得天独厚的人才资源和科研优势，是推动医药健康产业发展的理想之地。预计通过一系列政策支持和创新驱动，北京将能够在医药健康领域取得更加显著的成就，为全国乃至全球的医药健康产业贡献北京智慧和力量。
英语如下：
News Title: “Beijing Aims to Break the Trillion Yuan Mark in Pharmaceutical Health Industry by 2026”
Keywords: Pharmaceutical Industry, Beijing Goal, 1 Trillion Yuan Scale
News Content: The Beijing municipal government recently released the “Beijing Accelerates Pharmaceutical Health Coordinated Innovation Action Plan (2024-2026)” with the aim of driving the rapid development of the pharmaceutical health industry in the city. According to the plan, Beijing aims to increase the total scale of the pharmaceutical health industry to 1.25 trillion yuan within the next three years, while ensuring at least 10 billion yuan of fixed asset investment annually.
This goal not only demonstrates Beijing’s commitment to the pharmaceutical health industry but also predicts a rapid growth period for the sector in the coming years. The plan mentions that through strengthening the construction of innovation platforms, optimizing the industrial structure, and enhancing R&D capabilities, measures will be taken to push the pharmaceutical health industry towards a leap forward development.
As the capital of China, Beijing enjoys unique talent and research advantages, making it an ideal location for the development of the pharmaceutical health industry. It is expected that through a series of policy support and innovation-driven measures, Beijing will be able to achieve more significant achievements in the pharmaceutical health sector, contributing Beijing wisdom and strength to the national and global pharmaceutical health industries.
【来源】http://www.chinanews.com/cj/2024/05-23/10222294.shtml
Views: 2